<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://harvardscience.harvard.edu" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>all David A. Edwards stories</title>
 <link>http://harvardscience.harvard.edu/stories/person/1413</link>
 <description>Stories and external links referencing a person (RSS)</description>
 <language>en</language>
<item>
 <title>For those who live and breathe chocolate, a puff</title>
 <link>http://harvardscience.harvard.edu/node/20756</link>
 <description>&lt;!--paging_filter--&gt;</description>
 <pubDate>Tue, 28 Apr 2009 09:48:50 -0400</pubDate>
 <dc:creator>404132862</dc:creator>
 <guid isPermaLink="false">20756 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Inhaled tuberculosis vaccine may be more effective than injected vaccine</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/inhaled-tuberculosis-vaccine-may-be-more-effective-injected-vaccine</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;A novel aerosol version of the most common &lt;a title=&quot;&quot; href=&quot;http://www.cdc.gov/tb/faqs/qa_introduction.htm#Intro1&quot;&gt;tuberculosis&lt;/a&gt; (TB) vaccine, administered directly to the lungs as an oral mist, offers significantly better protection against the disease in experimental animals than a comparable dose of the traditional injected vaccine, researchers report this week (March 12) in the &lt;a title=&quot;&quot; href=&quot;http://www.pnas.org/&quot;&gt;Proceedings of the National Academy of Sciences &lt;/a&gt;(PNAS).&lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/inhaled-tuberculosis-vaccine-may-be-more-effective-injected-vaccine&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Wed, 12 Mar 2008 13:58:18 -0400</pubDate>
 <dc:creator>404132862</dc:creator>
 <guid isPermaLink="false">20190 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Students develop system to fight TB</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/students-develop-system-fight-tb</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;A new system developed by Harvard undergraduates delivers anti-tuberculosis drugs through an inhaler, increasing the likelihood that patients will take them over longer periods, and reducing the side effects of pills and injections. To test and market the system, the group has formed a nonprofit corporation called MEND (MEdicine in NeeD). &quot;It&#039;s the beginning of an effort to bring new technology from the labs and classrooms of Harvard to patients by the quickest means possible,&quot; according to David Darst, a 21-year-old junior.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/students-develop-system-fight-tb&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 26 Mar 2007 05:23:46 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3229 at http://harvardscience.harvard.edu</guid>
</item>
</channel>
</rss>
